Page last updated: 2024-09-05

cilengitide and Experimental Mammary Neoplasms

cilengitide has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bäuerle, T; Berger, MR; Goodman, SL; Komljenovic, D; Merz, M; Semmler, W1

Other Studies

1 other study(ies) available for cilengitide and Experimental Mammary Neoplasms

ArticleYear
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.
    International journal of cancer, 2011, May-15, Volume: 128, Issue:10

    Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Rats; Rats, Nude; Receptors, Vitronectin; Snake Venoms; Tomography, X-Ray Computed

2011